[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ skip to main content
10.1145/3107411.3107439acmconferencesArticle/Chapter ViewAbstractPublication PagesbcbConference Proceedingsconference-collections
research-article

TUCUXI: An Intelligent System for Personalized Medicine from Individualization of Treatments to Research Databases and Back

Published: 20 August 2017 Publication History

Abstract

Therapeutic Drug Monitoring (TDM) is a key concept in precision medicine. The goal of TDM is to avoid therapeutic failure or toxic effects of a drug due to insufficient or excessive circulating concentration exposure related to between-patient variability in the drug's disposition. We present TUCUXI - an intelligent system for TDM. By making use of embedded mathematical models, the software allows to compute maximum likelihood individual predictions of drug concentrations from population pharmacokinetic data, based on patient's parameters and previously observed concentrations. TUCUXI was developed to be used in medical practice, to assist clinicians in taking dosage adjustment decisions for optimizing drug concentration levels. This software is currently being tested in a University Hospital. In this paper we focus on the process of software integration in clinical workflow. The modular architecture of the software allows us to plug in a module enabling data aggregation for research purposes. This is an important feature in order to develop new mathematical models for drugs, and thus to improve TDM. Finally we discuss ethical issues related to the use of an automated decision support system in clinical practice, in particular if it allows data aggregation for research purposes.

References

[1]
Basma Al-Metwali and Hussain Mulla 2017. Personalised dosing of medicines for children. Journal of Pharmacy and Pharmacology (2017).
[2]
Manel Aouri, Catalina Barcelo, Monia Guidi, Margalida Rotger, Matthias Cavassini, Cédric Hizrel, Thierry Buclin, Laurent A Decosterd, Chantal Csajka, Swiss HIV Cohort Study, and others 2017. Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals. Antimicrobial Agents and Chemotherapy Vol. 61, 1 (2017), e00899--16.
[3]
AJ Boeckmann, LB Sheiner, and SL Beal 1994. NONMEM users guide. San Francisco: University of California San Francisco (1994).
[4]
Olivier Capitain, Andreaa Asevoaia, Michele Boisdron-Celle, Anne-Lise Poirier, Alain Morel, and Erick Gamelin 2012. Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II, proof-of-concept study. Clinical colorectal cancer Vol. 11, 4 (2012), 263--267.
[5]
Giulia Cappi, Fabio M Spiga, Yessica Moncada, Anna Ferretti, Michael Beyeler, Marco Bianchessi, Laurent Decosterd, Thierry Buclin, and Carlotta Guiducci 2015. Label-free detection of tobramycin in serum by transmission-localized surface plasmon resonance. Analytical chemistry, Vol. 87, 10 (2015), 5278--5285.
[6]
Alevtina Dubovitskaya, Visara Urovi, Imanol Barba, Karl Aberer, and Michael Ignaz Schumacher 2016. A Multiagent System for Dynamic Data Aggregation in Medical Research. BioMed Research International Vol. 2016 (2016).
[7]
Alevtina Dubovitskaya, Visara Urovi, Matteo Vasirani, Karl Aberer, and Michael Ignaz Schumacher 2015. A Cloud-based eHealth Architecture for Privacy Preserving Data Integration IFIP Advances in Information and Communication Technology (SEC 2015). Springer Science and Business Media.
[8]
Khaled El Emam, Sam Rodgers, and Bradley Malin. 2015. Anonymising and sharing individual patient data. bmj Vol. 350 (2015), h1139.
[9]
Aline Fuchs, Chantal Csajka, Yann Thoma, Thierry Buclin, and Nicolas Widmer 2013. Benchmarking therapeutic drug monitoring software: a review of available computer tools. Clinical pharmacokinetics Vol. 52, 1 (2013), 9--22.
[10]
Verena Gotta, Nicolas Widmer, Michael Montemurro, Serge Leyvraz, Amina Haouala, Laurent A Decosterd, Chantal Csajka, and Thierry Buclin 2012. Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels. Clinical pharmacokinetics Vol. 51, 3 (March 2012), 187--201.

Cited By

View all
  • (2024)Toward a Clinical Decision Support System for Monitoring Therapeutic Antituberculosis Medical Drugs in Tanzania (Project TuberXpert): Protocol for an Algorithm' Development and ImplementationJMIR Research Protocols10.2196/5872013(e58720)Online publication date: 21-Oct-2024
  • (2024)Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in NeonatesClinical Pharmacokinetics10.1007/s40262-024-01353-863:3(367-380)Online publication date: 28-Feb-2024
  • (2023)Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping ReviewPharmaceutics10.3390/pharmaceutics1507185915:7(1859)Online publication date: 1-Jul-2023
  • Show More Cited By

Index Terms

  1. TUCUXI: An Intelligent System for Personalized Medicine from Individualization of Treatments to Research Databases and Back

      Recommendations

      Comments

      Please enable JavaScript to view thecomments powered by Disqus.

      Information & Contributors

      Information

      Published In

      cover image ACM Conferences
      ACM-BCB '17: Proceedings of the 8th ACM International Conference on Bioinformatics, Computational Biology,and Health Informatics
      August 2017
      800 pages
      ISBN:9781450347228
      DOI:10.1145/3107411
      Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected]

      Sponsors

      Publisher

      Association for Computing Machinery

      New York, NY, United States

      Publication History

      Published: 20 August 2017

      Permissions

      Request permissions for this article.

      Check for updates

      Author Tags

      1. automated tdm
      2. clinical information system
      3. data integration
      4. personalized medicine

      Qualifiers

      • Research-article

      Funding Sources

      • SNSF Nano-Tera.ch

      Conference

      BCB '17
      Sponsor:

      Acceptance Rates

      ACM-BCB '17 Paper Acceptance Rate 42 of 132 submissions, 32%;
      Overall Acceptance Rate 254 of 885 submissions, 29%

      Contributors

      Other Metrics

      Bibliometrics & Citations

      Bibliometrics

      Article Metrics

      • Downloads (Last 12 months)19
      • Downloads (Last 6 weeks)1
      Reflects downloads up to 31 Dec 2024

      Other Metrics

      Citations

      Cited By

      View all
      • (2024)Toward a Clinical Decision Support System for Monitoring Therapeutic Antituberculosis Medical Drugs in Tanzania (Project TuberXpert): Protocol for an Algorithm' Development and ImplementationJMIR Research Protocols10.2196/5872013(e58720)Online publication date: 21-Oct-2024
      • (2024)Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in NeonatesClinical Pharmacokinetics10.1007/s40262-024-01353-863:3(367-380)Online publication date: 28-Feb-2024
      • (2023)Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping ReviewPharmaceutics10.3390/pharmaceutics1507185915:7(1859)Online publication date: 1-Jul-2023
      • (2023)Improving the Work Efficiency of Therapeutic Drug Monitoring Reports Through the Establishment of an Automated Data Transfer SystemAnnals of Laboratory Medicine10.3343/alm.2023.43.6.62843:6(628-631)Online publication date: 30-Jun-2023
      • (2023)Pharmacokinetic Consideration of Venetoclax in Acute Myeloid Leukemia Patients: A Potential Candidate for TDM? A Short CommunicationTherapeutic Drug Monitoring10.1097/FTD.0000000000001151Online publication date: 8-Nov-2023
      • (2022)Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted ChildrenPharmaceutics10.3390/pharmaceutics1410210714:10(2107)Online publication date: 1-Oct-2022
      • (2022)Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now?Pharmaceutics10.3390/pharmaceutics1408167414:8(1674)Online publication date: 11-Aug-2022
      • (2022)Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast CancerPharmaceutics10.3390/pharmaceutics1407131714:7(1317)Online publication date: 21-Jun-2022
      • (2022)Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosingJAC-Antimicrobial Resistance10.1093/jacamr/dlac0434:2Online publication date: 21-Apr-2022
      • (2021)Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulationJournal of Antimicrobial Chemotherapy10.1093/jac/dkab394Online publication date: 17-Nov-2021
      • Show More Cited By

      View Options

      Login options

      View options

      PDF

      View or Download as a PDF file.

      PDF

      eReader

      View online with eReader.

      eReader

      Media

      Figures

      Other

      Tables

      Share

      Share

      Share this Publication link

      Share on social media